Chen Size, Professor, Doctor, Chief Physician, Postdoctoral Co-supervisor of Immuno-oncology Department of the First Affiliated Hospital of Guangdong Pharmaceutical University, Director of Guangdong Esophageal Cancer Precision Therapy Engineering Technology Research Center, Director of Guangdong Provincial Key Laboratory of Cancer Immunotherapy, Postdoctoral Fellow United States Mayo Clinic, Visiting Scholar of National Cancer Institute, Member of ASCO and ESMO, Vice Chairman of Cancer Targeted Therapy Technology Branch of China Society of Biomedical Engineering,Chairman of Immune Cell and Stem Cell Therapy Branch of Guangdong Province Care Association, Chairman of Metabolism and Cancer Prevention and Treatment Committee of Guangdong Cancer Targeted Intervention Society, Chairman of Cancer Immunotherapy Branch of Guangdong Health Science Popularization Promotion Association, Lingnan Famous Doctor, Top Ten Southern Health Science Popularization Experts, presided over and participated in 9 national and provincial level projects and 3 CAR-T cell therapy for solid tumors Clinical trial Pl, took the lead in carrying out tumor immunization clinic in Guangdong Province, in Annals of Oncology,"Cell Death Differ" and other magazines published 50 academic papers, initiated the clinical trial of CAR-T cells with T cell knockout PD-1 in the treatment of non-small cell lung cancer and esophageal cancer in the world, and orally reported the progress of clinical trials at ESMO Conference.